An interpretable artificial intelligence approach to differentiate between blastocysts with similar or same morphological grades
Human Reproduction · 01.06.2025 · 40 (6) · 1077-1086
DOI: 10.1093/humrep/deaf066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 21.04.2025. Verfasst von Hang Liu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Blastocyst, Artificial Intelligence, Blastocyst Inner Cell Mass, Deep Learning. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Vector Institute and Temerty Faculty of Medicine, University of Toronto, Natural Science Foundation of Hunan Province of China.
Abstract (Originalsprache)
STUDY QUESTION Can a quantitative method be developed to differentiate between blastocysts with similar or same inner cell mass (ICM) and trophectoderm (TE) grades, while also reflecting their potential for live birth? SUMMARY ANSWER We developed BlastScoringNet, an interpretable deep-learning model that quantifies blastocyst ICM and TE morphology with continuous scores, enabling finer differentiation between blastocysts with similar or same grades, with higher scores significantly correlating with higher live birth rates. WHAT IS KNOWN ALREADY While the Gardner grading system is widely used by embryologists worldwide, blastocysts having similar or same ICM and TE grades cause challenges for embryologists in decision-making. Furthermore, human assessment is subjective and inconsistent in predicting which blastocysts have higher potential to result in live birth. STUDY DESIGN, SIZE, DURATION The study design consists of three main steps. First, BlastScoringNet was developed using a grading dataset of 2760 blastocysts with majority-voted Gardner grades. Second, the model was applied to a live birth dataset of 15 228 blastocysts with known live birth outcomes to generate blastocyst scores. Finally, the correlation between these scores and live birth outcomes was assessed. The blastocysts were collected from patients who underwent IVF treatments between 2016 and 2018. For external application study, an additional grading dataset of 1455 blastocysts and a live birth dataset of 476 blastocysts were collected from patients who underwent IVF treatments between 2021 and 2023 at an external IVF institution. PARTICIPANTS/MATERIALS, SETTING, METHODS In this retrospective study, we developed BlastScoringNet, an interpretable deep-learning model which outputs expansion degree grade and continuous scores quantifying a blastocyst’s ICM morphology and TE morphology, based on the Gardner grading system. The continuous ICM and TE scores were calculated by weighting each base grade’s predicted probability and summing the predicted probabilities. To represent each blastocyst’s overall potential for live birth, we combined the ICM and TE scores using their odds ratios (ORs) for live birth. We further assessed the correlation between live birth rates and the ICM score, TE score, and the OR-combined score (adjusted for expansion degree) by applying BlastScoringNet to blastocysts with known live birth outcomes. To test its generalizability, we also applied BlastScoringNet to an external IVF institution, accounting for variations in imaging conditions, live birth rates, and embryologists’ experience levels. MAIN RESULTS AND THE ROLE OF CHANCE BlastScoringNet was developed using data from 2760 blastocysts with majority-voted grades for expansion degree, ICM, and TE. The model achieved mean area under the receiver operating characteristic curve values of 0.997 (SD 0.004) for expansion degree, 0.903 (SD 0.031) for ICM, and 0.943 (SD 0.040) for TE, based on predicted probabilities for each base grade. From these predicted probabilities, BlastScoringNet generated continuous ICM and TE scores, as well as expansion degree grades, for an additional 15 228 blastocysts with known live birth outcomes. Higher ICM and TE scores, along with their OR-combined scores, were significantly correlated with increased live birth rates (P < 0.0001). By fine-tuning, BlastScoringNet was applied to an external IVF institution, where higher OR-combined ICM and TE scores also significantly correlated with increased live birth rates (P = 0.00078), demonstrating consistent results across both institutions. LIMITATIONS, REASONS FOR CAUTION This study is limited by its retrospective nature. Further prospective randomized trials are required to confirm the clinical impact of BlastScoringNet in assisting embryologists in blastocyst selection. WIDER IMPLICATIONS OF THE FINDINGS BlastScoringNet provides an interpretable and quantitative method for evaluating blastocysts, aligned with the widely used Gardner grading system. Higher OR-combined ICM and TE scores, representing each blastocyst’s overall potential for live birth, were significantly correlated with increased live birth rates. The model’s demonstrated generalizability across two institutions further supports its clinical utility. These findings suggest that BlastScoringNet is a valuable tool for assisting embryologists in selecting blastocysts with the highest potential for live birth. The code and pre-trained models are publicly available to facilitate further research and widespread implementation. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by the Vector Institute and the Temerty Faculty of Medicine at the University of Toronto, Toronto, Ontario, Canada, via a Clinical AI Integration Grant, and the Natural Science Foundation of Hunan Province of China (2023JJ30714). The authors declare no competing interests. TRIAL REGISTRATION NUMBER N/A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON, Canada.
- Institute of Reproductive and Stem Cell Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan Province, China.
- Reproductive & Genetic Hospital of CITIC-Xiangya, Changsha, Hunan Province, China.
- NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan Province, China.
- Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive & Genetic Hospital of CITIC-Xiangya, Changsha, Hunan Province, China.
- Hengyang Nanhua-Xinghui Reproductive Health Hospital, Hengyang, Hunan Province, China.
ORCID-Profile: Hang Liu, Longbin Chen, Guanqiao Shan, Shuoping Zhang, Shanshan Wang, Haixiang Sun, Ge Lin, Yu Sun, Yifan Gu
Förderung
- Vector Institute and Temerty Faculty of Medicine, University of Toronto
- Natural Science Foundation of Hunan Province of China
Zitieren
APA
Liu, H., Chen, L., Shan, G., Sun, C., Lu, C., Liao, H., Zhang, S., Dong, S., Xu, X., Yan, Q., Gong, F., Zhang, Z., Dai, C., Chen, W., Song, H., Chen, L., Wang, S., Sun, H., Lin, G., …, & Gu, Y. (2025). An interpretable artificial intelligence approach to differentiate between blastocysts with similar or same morphological grades. Human Reproduction, 40(6), 1077-1086. https://doi.org/10.1093/humrep/deaf066
Vancouver
Liu H, Chen L, Shan G, Sun C, Lu C, Liao H, et al. An interpretable artificial intelligence approach to differentiate between blastocysts with similar or same morphological grades. Human Reproduction. 2025;40(6):1077-1086. doi:10.1093/humrep/deaf066
BibTeX
@article{Liu2025,
author = {Liu, Hang and Chen, Longbin and Shan, Guanqiao and Sun, Chen and Lu, Changfu and Liao, Hongqing and Zhang, Shuoping and Dong, Shaonan and Xu, Xinxin and Yan, Qiuyun and Gong, Fei and Zhang, Zhuoran and Dai, Changsheng and Chen, Wenyuan and Song, Haocong and Chen, Lei and Wang, Shanshan and Sun, Haixiang and Lin, Ge and Sun, Yu and Gu, Yifan},
title = {An interpretable artificial intelligence approach to differentiate between blastocysts with similar or same morphological grades},
journal = {Human Reproduction},
year = {2025},
volume = {40},
number = {6},
pages = {1077--1086},
doi = {10.1093/humrep/deaf066}
}
EUVIMED